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Abstract
Strokes and TIAs, with their high cumulative mortality and morbidity rates, are occurring with increasing frequency
in western population [1,4]. As such, it is vital for clinicians to provide optimal medical management in the perio-
perative period for those patients with this common neurological problem. This review aims to highlight the
importance of the perioperative period and the stages of pre-optimization that can be taken by the multi-disciplin-
ary team to aid this [17-19]. The evidence suggests that there are significant physiological advantages to early inva-
sive monitoring and high dependency care in these complex patients. These cohort of patients are at increased
risk of development of respiratory, gastrointestinal, nutritional and electrolyte disturbances so a constant vigil
should be exercised in early recognition and treatment.
Introduction
Peri- and post-operative care of the patient with neuro-
logic illness poses a clinical and logistical challenge for
the team participating in the care of the patient. The
management of patients with cerebrovascular disease
undergoing surgery requires an understanding of the
pathophysiological mechanisms involved. This enables
appropriate selection of patients who are suitable for
surgery, with pre-optimization and vigilance to avoid
predictable complications, as well as continued evalua-
tion to detect any peri-operative deterioration.
A) Stroke
A Transient Ischaemic Attack (TIA) occurs when there
is a change to the blood supply of an area of the brain
resulting in a change in neurologic function lasting for
less than 24 hours. If the neurological dysfunction per-
sists for up to 72 hours, but resolves, this is termed a
Reversible Ischaemic Neurological Defect (RIND). When
the neurological dysfunction persists for more than 72
hours, it is categorised as a stroke.
i) Ischaemic and haemorrhagic stroke (CVA)
Stroke is the third leading cause of death and affects
5.1% of the general population in the United States. In
Europe the incidence ranges from 101 to 239 per
100000 population [1,2]. Strokes commonly can be sub-
divided into haemorrhagic or ischaemic; such as the
middle cerebral artery occlusion and infarct illustrated
in Figure 1. The incidence of stroke increases with age;
with over 75% occurring after the 65 years of age.
Ischaemic stroke contribute to 87% of all strokes. The
rest (13%) are accounted for by non-traumatic haemor-
rhagic strokes [3]. Hemorrhagic strokes can be further
divided into intracerebral haemorrhage and subarach-
noid haemorrhage (SAH). Unlike ischaemic strokes, hae-
morrhagic strokes are not associated with transient
ischaemic attacks. The cumulative mortality for the
ischaemic stroke at five years after first-ever stroke is
60.1% [4]. The overall mortality for the haemorrhagic
strokes is high when compared to the ischaemic stroke
a n dt h er i s ko fm o r t a l i t yi su pt o5 2 %i nf i r s tt w od a y s
[5,6].
When evaluating a patient preoperatively with ischae-
mic or haemorrhagic stroke the following should be
considered -
[1] Cause of the stroke (Table 1)
[2] Patient risk factors (Table 2)
[3] Prognosis of the patient - is the surgery appropri-
ate? (Tables 3 and 4)
[4] Patient risk factors for development of death fol-
lowing a TIA (Table 5)
ii) Stroke: Transient ischaemic attacks
Transient ischaemic attacks are much more common
than strokes and occur in up to one in fifteen patients
over 65 years [13]. The 90 day risk for a stroke after a
TIA is 3% to 17.3% and is at its highest within the first
30 days after a TIA. Approximately half of patients who
experience a TIA fail to report it to their healthcare
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in the first 12 months.
Prevention of ischaemic strokes and the transient
ischaemic attacks
The management strategies for the prevention of ischae-
mic strokes and infarcts are summarised in table 6
[17-19]. Prevention of the haemorrhagic stroke is
achieved by the reduction of contributing risk factors.
Addressing all secondary prevention strategies decreases
the risk of further stroke, and as such, should be taken
into account during pre-operative assessment.
Initial assessment and treatment of ischaemic strokes [18]
Patients who have an acute TIA or stroke with a good
recovery should be commenced on appropriate antiplat-
let therapy and risk factors such as hypertension should
be dealt with promptly prior to referral to a specialist
neurovascular clinic. If there is evidence of more than
one TIA in 24 hours, ideally the patient should be
admitted to hospital and investigated as an inpatient.
Initial neurological assessment should focus on the
area of the brain affected and imaging of the brain (typi-
cally CT) should be arranged as soon as possible (< 24
hours). Imaging should be performed as an emergency if
there are any suggestions of high risk features such as
anticoagulant treatment, bleeding tendency and
depressed level of consciousness including unexplained
progressive or fluctuating symptoms. Other worrying
features include papilloedema, neck stiffness or fever
and severe headache at onset. Indications for thromboly-
sis or early anticoagulation, which is discussed below,
must be considered. Furthermore, in addition to routine
the observations, which should include conscious level,
blood pressure, pulse, heart rhythm, temperature, oxy-
gen saturation and hydration; the patients should be
screened for evidence of aspiration/swallowing difficul-
ties. Baseline investigations should include a full blood
count, clotting screen, blood sugar, urea and electrolytes
and an electrocardiogram.
Indications for thrombolysis
Thrombolysis (e.g. alteplase)s h o u l db ep e r f o r m e da f t e r
consultation with an experienced physician and within
three hours of the onset of imaging confirmed ischaemic
stroke (Class I, Level of Evidence); intra-arterial throm-
bolysis should be reserved for centres with interven-
tional neuroradiology services.
Acute treatment of intracerebral bleeds
Surgical intervention should be considered in cases of
supratentorial haemorrhage with mass effect or posterior
fossa/cerebellar haematoma. Neurosurgical opinion
should be sought for cases of secondary hydrocephalus
following the intracerebral bleed.
Acute treatment of Subarachnoid Haemorrhage (SAH)
Whilst trauma remains the commonest cause of SAH,
ruptured intracranial aneurysms account for 80% of
non-traumatic cases. However, it remains standard, that
regardless of cause, all cases should be referred for neu-
rosurgical consideration unless the patient is for pallia-
tive treatment only. SAH is treated with either
endovascular coiling or an open clipping (depending on
the centre experience and availability of interventional
Figure 1 Showing a perfusion scan and a CT scan of a patient
with a Left middle cerebral artery infarct [12][modified from
reference [13]].
Table 1 Underlying mechanisms of haemorrhagic and ischaemic stroke 3
Ischaemic stroke Haemorrhagic stroke
Thrombus - from a ulcerated plaque in the carotid artery Hypertension is the commonest - causing weakness of the vessel wall
Cardioembolism from Atrial fibrillation (AF) Amyloid angiopathy
Large vessel atherosclerosis causing a stroke by occlusion Use of sympathomimetic drugs such as cocaine causing transient
hypertension
Small deep perforating vessel arthrosclerosis causing lacunar stroke Congenital Arterio-venous malformations, aneurysms
A venous clot, causing paradoxical embolism through a patent foramen
ovale (PFO)
Uncommon such as tumours, vasculitis, bleeding diathesis and use of
anticoagulants
Vasospasm of structurally normal vessels (e.g. sympathomimetic drug
use)
Hypercoagulable state, operating with any of these mechanisms or
independently
Veenith et al. International Archives of Medicine 2010, 3:33
http://www.intarchmed.com/content/3/1/33
Page 2 of 5neuroradiologists/neurosurgeons). Acute complications
such as hydrocephalus may require an external ventricu-
lar drain to stabilise the patient and assess potential for
neurological recovery. A detailed discussion is outside
the scope of this review [20].
Perioperative implications for patients with a history of
stroke [21]
Patients with a history of stroke frequently have coexist-
ing vascular disease. Therefore, the overall management
aim is protection against further strokes as well as pre-
vention of further damage to other organs.
T h e s ep a t i e n t sm o s t l yh a v em u l t i p l ev e s s e li n v o l v e -
ment including the coronary arteries. They are also
likely to suffer from other co morbidities such as hyper-
tension and/or diabetes mellitus. Chronic hypertension
shifts the cerebral autoregulation curve to the right, ren-
dering the patients vulnerable to the haemodynamic
compromise and the stress associated with the surgery
[12]. Relative hypotension may increase the risk of end
organ ischaemia. To avoid these complications invasive
monitoring may be necessary in the perioperative period
with consideration for high dependency care
postoperatively.
Complications following the illness
Care is required to reduce the incidence of complica-
tions potentiated by the presence of focal neurological
deficits, as well as those related to coexisting illnesses.
Respiratory complications following a CVA [22]
Alterations of respiratory control, mechanics, and pat-
tern are common following a CVA and lead to gas
exchange abnormalities. Central or obstructive sleep
apnoea may occur. Immobility can cause further compli-
cations such as hypostatic or aspiration pneumonia and
venous thromboembolism. Many of these patients
would need admission to a critical care areas following
surgery for these reasons.
GI complications [23]
These patients may be at increased risk of aspiration
due to impaired swallowing, ineffective cough and
reduced gastric emptying.
Nutrition [24]
Poor nutritional intake following the stroke may lead to
malnutrition and may be associated with poor survival
and functional outcomes after the surgery.
Dyselectrolemia
Strokes are notoriously associated with electrolytic dis-
turbances for a variety of reasons. These include poor
nutritional intake [24], dyselectrolemia directly related
to the stroke [25] (acutely and associated cardiac
arrhythmias) and diuretics [26] used for the treatment
of hypertension.
Drug therapy and perioperative period
The team should be mindful of the hypercoagulable
state created by the withdrawal of the drugs (such as
statins and antithrombotic antiplatlet aggregation drugs)
prior to surgery. This is often necessary to minimise
surgical complications related to bleeding, but may also
occur as a result of fasting. The risks/benefits of with-
drawing such drugs need to be considered on a patient
by patient basis.
Conclusion
Stroke is the third leading cause of death in Europe [1]
and has a cumulative mortality at 5 years of 60.1 [4]. A
Table 2 Risk factors for the development of stroke 3578910
Ischaemic stroke Haemorrhagic stroke
Common traditional factors
Hypertension, previous transient ischaemic attacks, Smoking, Diabetes Mellitus, AF,
Cardiovascular diseases (MI, angina, Peripheral vascular diseases) and heart failure
Common traditional factors
Male sex, age, hypertension, diabetes mellitus
and alcohol intake.
Haemostatic factors - factor VIIIc and von Willebrand factor Haemostatic factors - Use of the anticoagulants
and antiplatlet agents
Non traditional factors - Waist hip ratio, Left ventricular hypertrophy, Apolipoprotein(a) levels
and White cell counts suggestive of inflammation
Non traditional factors - Previous TIA’s
Table 3 Predictors of death for the haemorrhagic (predicting death and disability at 30 days) and ischaemic strokes
(death and disability at 100 days) 611
Haemorrhagic stroke Ischaemic stroke
Size and location The volume of ICH and location Right and left arm paresis at admission, lenticulostriate infarction
Premorbid status Age, sex, prior stroke and Diabetes
Severity at
presentation
The Glasgow Coma Scale (GCS) on
admission
National institutes of health Stroke Scale at admission and Rankin Scale 48-72
hours later
Complications Hydrocephalus Fever, neurological complications.
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90 days [14]. As well as mortality strokes confer a signif-
icant morbidity.
A careful approach must be taken to the evaluation of
a patient who has had a previous stroke in determining
whether they are fit for an unrelated surgical procedure.
A multidisciplinary approach is required to first ascer-
tain whether surgery is the most appropriate treatment
option. This must take into account the estimated mor-
bidity and mortality, the post-operative facilities avail-
able for rehabilitation, and of course the patient’s
wishes.
Pre-optimization is desirable in patients undergoing
elective procedures. Following a stroke or TIA all rele-
vant secondary prevention strategies should be
addressed as per the latest American Heart Association
(AHA)/American Stroke Association (ASA) guidelines
of October 2010 [19]. This should include risk factor
management, medical therapies, and surgical interven-
tions as appropriate.
Table 4 Favourable predictors of ischaemic and
haemorrhagic stroke 4
Haemorrhagic stroke Ischaemic stroke
Cortical location Location and good function at presentation
Mild neurological
dysfunction
Mild neurological dysfunction
Low fibrinogen levels Absence of AF as this predicts more
Cardiovascular deaths
Table 5 Risk factors increasing mortality following TIA
Risk factors for development of death following a TIA
Previous strokes
Stroke in heavy smokers - > 40 per day (level comes to normal after 5
years of stopping)
Atrial Fibrillation -increasing risk about 5-fold
Diabetes, hypertension, MI and high cholesterol
Race - African American race has higher incidence
Conjugate equine oestrogen increased risk of ischemic stroke and TIAs
by 55%
Table 6 Reduction strategies for the prevention of TIA and ischaemic strokes
Strategy Evidence
Risk factor
management
Hypertension Class I, Level of Evidence A, Benefit has been associated with an average reduction of
&10/5 mm Hg (Normal defined by JNC 7 criteria as 120/80 mmHg). Drugs should be
optimised to the target patient (consider the cardiac history, DM etc)
Diabetes mellitus Class I, Level of Evidence A, Rigorous control of hypertension and intensive lipid lowering
treatment, any drugs appropriate and most often > 1 drug needed.
Hypercholesterolemia Class I, Level of Evidence A, Lifestyle modification, dietary guidelines and statins
Cigarette Smoking Class I, Level of Evidence C, Strongly advise every patient with stroke or TIA to quit
Alcohol Intake Class I, Level of Evidence A. Heavy drinkers should eliminate or reduce their consumption
of alcohol.(it is actually a J-shaped association between alcohol and ischemic stroke, with
a protective effect in light or moderate drinkers and an elevated stroke risk with heavy
alcohol consumption)
Obesity Class IIb, Level of Evidence C. BMI of between 18.5 and 24.9 kg/m
2 and a waist
circumference of < 35 in for women and < 40 in for men
Physical inactivity Class IIb, Level of Evidence C. At least 30 minutes of moderate-intensity physical exercise
Interventional
Approaches
Carotid endartrectomy(CEA) Class I, Level of Evidence A. TIA or ischemic stroke within the last6 months and severe
(70% to 99%) carotid artery stenosis, CEA by a surgeon with a peri-operative morbidity
and mortality of < 6%. Consider CEA for certain high risk candidates with moderate
stenosis (50-99%). If the TIA preferably within 2 weeks of after TIA.
Carotid angioplasty and stenting may be suitable for some patients with symptomatic
high-grade stenosis and factors that make CEA unfavourable.
Extracranial Vertebrobasilar Disease/
Intracranial Atherosclerosis
Class IIb, Level of Evidence C Endovascular treatment - when patients are having
symptoms despite medical therapies
Medical
Treatments
Cardiogenic Embolism and PAF Class I, Level of Evidence A, paroxysmal (intermittent) AF, anticoagulation with adjusted-
Dose Warfarin (target INR, 2.5; range, 2.0 to 3.0). Aspirin to be given in those patients with
a clear contra-indication to Warfarin.
Cardiogenic Embolism - LV thrombus Oral anticoagulation is reasonable, aiming for an INR of 2.0 to 3.0 for at least 3 months
and up to 1 year (Class IIa, Level of Evidence B)
Noncardioembolic ischemic stroke or
TIA
(Class IIa, Level of Evidence A) Aspirin (50 to 325 mg/d), the combination of aspirin and
extended-release dipyridamole, and clopidogrel are all acceptable options for initial
therapy. Aspirin to clopidogrel increases the risk of haemorrhage and is not routinely
recommended for ischemic stroke or TIA patients (Class III, Level of Evidence A).
Patent Foramen Ovale PFO closure may be considered for patients with recurrent cryptogenic stroke despite
optimal medical therapy (Class IIb, Level of Evidence C)
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e x i s t i n gv a s c u l a rd i s e a s ea n da r em o r el i k e l yt os u f f e r
from co-morbidities like diabetes mellitus, hyperten-
sion, and ischaemic heart disease. The peri-operative
team should aim to protect the patient from risk of
further stroke, as well as to limit any further organ
damage from hypoperfusion in these high-risk indivi-
duals. As such invasive monitoring is desirable, and
consideration should be made to possible high-depen-
dency care post-operatively.
Complications secondary to stroke must be appre-
ciated and addressed in the post-operative period. These
include the risk of venous thromboembolism related to
decreased mobility associated with stroke, which will be
potentiated by most surgical procedures. Stroke patients
also have an increased risk of aspiration pneumonia
[23,24]. Poor nutritional intake following the stroke may
lead to malnutrition and may be associated with poor
survival and functional outcomes after the surgery. Elec-
trolyte abnormalities are commonly associated with
strokes and may lead to dysrhythmias both peri- and
post-operatively [24,25]. If anti-platelet drugs are with-
drawn for surgical considerations the team should be
aware of the increased risk of thrombosis.
The patient with a history of stroke undergoing sur-
gery is high-risk, and requires careful pre-operative eva-
luation, pre-optimaztion, and close monitoring for
predictable post-operative complications.
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